KORU Medical Systems Approaches Critical Q3 Earnings Milestone

All eyes are on KORU Medical Systems as the medical technology firm prepares to release its third-quarter 2025 financial results on November 12. Following an exceptional previous quarter and an upgraded full-year outlook, the upcoming report represents a crucial test for the company’s sustained growth trajectory.

The company enters this earnings period with significant momentum from its second-quarter achievements. KORU Medical Systems demonstrated robust expansion across multiple segments, with total revenue climbing 21% to exceed $10 million. International operations showed particular strength, advancing 34% year-over-year, while pharmaceutical services recorded an impressive 42% growth rate.

Although gross margins experienced a modest contraction to 63.5%, the organization maintains a solid financial foundation with $8.1 million in cash reserves. Management’s Read more...